LYEL Stock Summary and Trading Ideas (Lyell Immunopharma | NASDAQ:LYEL)

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

What symbol and exchange does Lyell Immunopharma shares trade?

Lyell Immunopharma trades on the NASDAQ stock market under the symbol LYEL.

What is Lyell Immunopharma stock price doing today?

As of January 22, 2026, LYEL stock price climbed to $25.84 with 79,517 million shares trading.

What is Lyell Immunopharma's Beta?

LYEL has a beta of 1.54, meaning it tends to be more sensitive to market movements. LYEL has a correlation of 0.08 to the broad based SPY ETF.

How much is Lyell Immunopharma worth?

LYEL has a market cap of $548.94 million. This is considered a Small Cap stock.

What is the highest and lowest price Lyell Immunopharma traded in the last 3 year period?

In the last 3 years, LYEL traded as high as $79.40 and as low as $7.65.

What are the top ETFs holding Lyell Immunopharma?

The top ETF exchange traded funds that LYEL belongs to (by Net Assets): VTI, VXF, DWAS, SCHA, IBB.

Is Lyell Immunopharma (LYEL) a good investment?

LYEL has outperformed the market in the last year with a price return of +127.1% while the SPY ETF gained +15.5%. LYEL has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +49.2% and +3.2%, respectively, while the SPY returned +2.9% and -0.1%, respectively.

What are the support and resistance levels for Lyell Immunopharma (LYEL)?

LYEL support price is $22.49 and resistance is $25.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LYEL shares will trade within this expected range on the day.